Negligence regarding cannabis derivatives can result in charges of negligence, omission, and even drug trafficking

After receiving an action plan from the Union, the 1st Section of the STJ extends the deadline for delivering regulations on the production and access to cannabis for medicinal use

Decision reaffirms the six-month deadline for implementing rules on hemp for medicinal, pharmaceutical, and industrial use

This data is from Kaya Mind and refers to associations with individual or collective habeas corpus for cultivation; the country has 147,000 patients served, totaling 259 associations in operation

In the country, the use of cannabis derivatives in cosmetics is prohibited

Unprecedented decision by the Superior Court of Justice allows a group from Peruíbe (SP) to cultivate cannabis for therapeutic purposes, paving the way for new legal and medical debates on the medicinal use of the plant

Historic decision establishes parameters for the production of industrial hemp for medicinal and pharmaceutical purposes. The Union has yet to comment on deadlines.

Unanimous decision by the 3rd Chamber of Public Law benefits woman; rapporteur cites STJ criteria

Unanimous decision by the Fifth Panel reinforces patients' right to therapeutic planting upon medical proof and highlights the topic in an official report

CNJ re-evaluated nearly 30,000 cases involving cannabis, only 13% of convictions were changed; experts point to the influence of the 'police word' and institutional resistance in state courts

Favorable decision to Biomagistral network allows the production of formulations with Cannabidiol under prescription